Terumo
Terumo BCT Asia Pte. Ltd., based in Singapore, operates in over 160 countries, providing more than 50,000 products and services in the vascular business and other medical fields.
Company Overview
Terumo is a global medical technology company with operations spanning over 160 countries and regions. The company offers an extensive portfolio of more than 50,000 products and services, primarily focused on the vascular business, including surgical grafts and stent grafts. Terumo leverages digital technology to provide optimized solutions for individual patients. Headquartered in multiple locations including Singapore, USA, Canada, Europe, and Asia, Terumo is committed to contributing to healthcare, society, and the global environment.
Global Presence
Terumo has a significant global footprint, with headquarters and branches across various continents. Key locations include Terumo BCT Asia in Singapore, Terumo Medical Corporation in New Jersey, USA, Terumo Cardiovascular Systems in Michigan, USA, and Terumo Europe in Zaventem, Belgium. The company also has locations in China, Japan, India, Germany, Brazil, and many other countries. This widespread presence allows Terumo to effectively serve diverse markets around the world.
Product Portfolio
Terumo's product portfolio is comprehensive, particularly in the vascular business. The company offers various surgical grafts and stent grafts. Additionally, Terumo develops innovative products utilizing digital technology to deliver patient-specific healthcare solutions. Their product line includes the Individualized Nomogram for the Rika Plasma Donation System, which has been cleared by the FDA to increase collection volume without extending collection time.
Sustainability Efforts
Terumo is actively committed to reducing its environmental impact by lowering greenhouse gas emissions and minimizing waste from its business operations. The company has established several key sustainability themes focusing on resolving issues related to healthcare, society, and the global environment. Furthermore, Terumo engages in various social contribution activities to support the communities where it operates.
Awards and Recognitions
Terumo has received several prestigious awards recognizing its innovations and contributions to medical technology. The company won the Prime Minister’s Award for the R&D, practical application, and dissemination of ECMO. Terumo Aortic received the King’s Award for Innovation. Additionally, Terumo Blood and Cell Technologies is partnering with CiRA Foundation to develop automated iPS cell manufacturing.